Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Terminated(2)
Other(2)

Detailed Status

Completed4
unknown2
Withdrawn2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (28.6%)
N/A5 (71.4%)

Trials by Status

unknown220%
withdrawn220%
completed440%
recruiting220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10